UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-07, Vol.386 (9991), p.360-368

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of a Cell-Culture–Derived Quadrivalent Influenza Vaccine in Children

The New England journal of medicine, 2021-10, Vol.385 (16), p.1485-1495

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of a C1 Esterase Inhibitor Concentrate in Elderly Patients with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB245-AB245

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Journal of hypertension, 2002-09, Vol.20 (9), p.1879-1886

2002

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Inhibitory Antibody Formation in Subjects with Hereditary Angioedema Treated with Plasma-Derived C1-Esterase Inhibitor Concentrate (Berinert®)

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB247-AB247

2016

Link zum Volltext

Verfügbarkeit prüfen

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial

Journal of allergy and clinical immunology, 2007-04, Vol.119 (4), p.916-923

2007

Link zum Volltext

Verfügbarkeit prüfen

Safety of a C1 Esterase Inhibitor Concentrate in Pregnant Women with Hereditary Angioedema: Findings from the International Berinert Patient Registry

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB243-AB243

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Modeling Predicts Different IgG Exposures Using Different IVIG-Scig Dose Conversion Factors In Patients With Primary Immune Deficiency

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB181-AB181

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of a C1 Esterase Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary Angioedema: Findings from a Large International Registry

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB193-AB193

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Usage of a C1 Esterase Inhibitor Concentrate for Hereditary Angioedema: Final Results from a Large International Registry

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB192-AB192

2015

Link zum Volltext

Verfügbarkeit prüfen

Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study

European journal of heart failure, 2011-04, Vol.13 (4), p.384-391

2011

Link zum Volltext

Verfügbarkeit prüfen

The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year

Annals of allergy, asthma, & immunology, 2010-08, Vol.105 (2), p.174-181

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study

Pharmacogenetics and genomics, 2010-02, Vol.20 (2), p.77-85

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of montelukast and beclomethasone on airway function and asthma control

Journal of allergy and clinical immunology, 2002-12, Vol.110 (6), p.847-854

2002

Link zum Volltext

Verfügbarkeit prüfen

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

JAMA : the journal of the American Medical Association, 2004-11, Vol.292 (19), p.2343

2004

Link zum Volltext

Verfügbarkeit prüfen

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

Circulation (New York, N.Y.), 2004-09, Vol.110 (11), p.1456-1462

2004

Link zum Volltext

Verfügbarkeit prüfen

All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy

European heart journal, 2010-09, Vol.31 (18), p.2271-2279

2010

Link zum Volltext

Verfügbarkeit prüfen

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study

Annals of allergy, asthma, & immunology, 2004-06, Vol.92 (6), p.641-648

2004

Link zum Volltext

Verfügbarkeit prüfen

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension

JAMA : the journal of the American Medical Association, 2006-09, Vol.296 (10), p.1242

2006

Link zum Volltext

Verfügbarkeit prüfen

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Nature communications, 2024-05, Vol.15 (1), p.4081-4081, Article 4081

2024

Link zum Volltext

Verfügbarkeit prüfen

Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients

Annals of internal medicine, 2007-09, Vol.147 (5), p.311

2007

Link zum Volltext

Verfügbarkeit prüfen

Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency

British journal of clinical pharmacology, 2017-11, Vol.83 (11), p.2386-2397

2017

Link zum Volltext

Verfügbarkeit prüfen

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

Circulation (New York, N.Y.), 2003-08, Vol.108 (6), p.684-690

2003

Link zum Volltext

Verfügbarkeit prüfen

ADVANTAGE: science first, marketing second

Annals of internal medicine, 2008-11, Vol.149 (10), p.773; author reply 773

Edelman, Jonathan M

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(147)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(99)
Life Sciences & Biomedicine
(95)
Humans
(80)
Male
(57)
Biological And Medical Sciences
(53)
Female
(53)
Medical Sciences
(48)
Middle Aged
(48)
Aged
(43)
Adult
(30)
Double-Blind Method
(28)
Antihypertensive Agents - Therapeutic Use
(26)
Cardiovascular System & Cardiology
(26)
Aged, 80 And Over
(24)
Hypertension
(24)
Hypertension - Drug Therapy
(24)
Losartan - Therapeutic Use
(23)
Atenolol - Therapeutic Use
(22)
Treatment Outcome
(22)
Pharmacology. Drug Treatments
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

Efficacy of a Cell-Culture–Derived Quadrivalent Influenza Vaccine in Children

Use of a C1 Esterase Inhibitor Concentrate in Elderly Patients with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Assessment of Inhibitory Antibody Formation in Subjects with Hereditary Angioedema Treated with Plasma-Derived C1-Esterase Inhibitor Concentrate (Berinert®)

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial

Safety of a C1 Esterase Inhibitor Concentrate in Pregnant Women with Hereditary Angioedema: Findings from the International Berinert Patient Registry

Pharmacokinetic Modeling Predicts Different IgG Exposures Using Different IVIG-Scig Dose Conversion Factors In Patients With Primary Immune Deficiency

Efficacy and Safety of a C1 Esterase Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary Angioedema: Findings from a Large International Registry

Clinical Usage of a C1 Esterase Inhibitor Concentrate for Hereditary Angioedema: Final Results from a Large International Registry

Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study

The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study

Effects of montelukast and beclomethasone on airway function and asthma control

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients

Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

ADVANTAGE: science first, marketing second

Suchergebnisse filtern